Abbott Laboratories

$75 Million Drug Deal Between Abbott and Neurocrine

$75 Million Drug Deal Between Abbott and Neurocrine

The international pharmaceutical company Abbott has reported to purchase all the exclusive rights to manufacture and sell Elagolix.

In a meeting on Wednesday, Abbott Laboratories said that they have signed a deal worth $75 million with Neurocrine Biosciences. Neurocrine will also be entitled to a further sum of around $500 million.

Elagolix is a treatment which is basically used to cure the gynecological pain. The drug can also provide a great help for curing uterine fibroids or other problems associated with uterus at the time of pregnancy.

Abbott’s New Laboratory

Abbott’s New Laboratory

Health care company Abbott has set up its largest nutrition R&D facility outside of the United States at the Biopolis Research Park in Singapore. The new US $20 million (S $27-million) laboratory will focus on developing products specifically designed for Asians.

Currently, the laboratory employs forty scientists, with Abbott hoping to increase the headcount to over 60 in the next two years. Abbott said 90% of this talent pool will be drawn from Singapore and the region.

FDA Shared Preliminary Review of Diet Drug Meridia based on Study

Weightloss Pill Meridia FDA

The US Food and Drug Administration is currently in the process of reviewing a new diet drug Meridia, and while a final stance is still awaited, the agency has revealed preliminary data on the drug, according to which certain patients indulging in the long term use of the drug could be exposing themselves to an increased risk of heart attacks, strokes and come other serious cardiovascular problems. The revelation is based on findings put forward by a new study.

Syndicate content

Latest News

Samsung unveils Apple iPad’s rival; raises 2010 smartphone sales target
Apple’s Ping social network is impressive
HP beats Dell in bid war for 3PAR
Wavering Housing Industry Might Halt Economic Revival
WebOS 2.0 comes with true multitasking features
Royal Bank of Scotland Cutting Down the Staff
According to a Survey, Smokers Are Not Accepted Anymore
Regular Screening of Colorectal Cancer is Necessary
World’s Biggest Coffee Morning Has a Challenge to raise £55,000
Energy Policy a Top Issue for New Brunswickers
Northern Ireland has the Lowest Economic Activity in UK
Figures Suggest Increase in the Number of Vaccinated Children